Trial Profile
A Long-term, Non-comparative, Multi-centre Study to Evaluate the Efficacy and Safety of 0.1% and 0.03% Tacrolimus (FK506) Ointment Administered in Adults With Moderate to Severe Atopic Dermatitis FG-506-06-IT-01
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Oct 2014
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Atopic dermatitis
- Focus Registrational; Therapeutic Use
- Sponsors Astellas Pharma
- 21 Apr 2014 New trial record